MedTrace Logo

Mechanisms of Atrial Pathoelectrophysiology in HCM

NCT07454135 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2026-04-06

No results posted yet for this study

Summary

This study aims to learn why atrial fibrillation (AF), a type of irregular heartbeat, happens more often and is harder to treat in people with hypertrophic cardiomyopathy (HCM). HCM is an inherited condition where the heart muscle is thicker than usual.

Researchers will study electrical signals from the heart and advanced heart imaging. By doing this, they hope to better understand how AF behaves in people with HCM and why treatments may not work as well for them.

The information from this study may help improve future treatments for people who have both HCM and AF.

Conditions

  • Hypertrophic Cardiomyopathy (HCM)
  • Atrial Fibrillation (AF)

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-08
Primary Completion
2027-09-30
Completion
2027-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07454135 on ClinicalTrials.gov